Medtor’s technology has been proven to significantly outperform current technology in a series of independent clinical studies, delivering the highest motion-tolerant Sp02 accuracy ever available.

Medtor is an early revenue-stage privately funded entity located in Manhattan Beach, CA, and focused on leveraging patented optical technology to bring medical-grade vital signs monitoring to wearable platforms. The company has already developed a complete medical OEM solution, including wired sensors and hardware module, which has been validated in several independent clinical studies and is pending FDA clearance. Medtor is actively seeking technology partners for developing and marketing our vital sign technologies.